Pharmaceutical and Biotechnology Patent Life Cycles and Portfolio Strategies Conference

This conference focuses on the rapidly shifting legal and regulatory environment surrounding pharmaceuticals and biotechnology patent life cycles and portfolio strategies, and will address novel biopharmaceutical controversies in a post- Hatch-Waxman and BPCIA world. Theresa Kavanaugh will speak on a panel titled "Exclusivities: New Developments, Controversies and Concerns for Small and Large Molecules and Combination Products."

For more information, please visit: http://www.americanconference.com/BioPharmaLifeCycles.